-
Product Insights
Innovations in Hospital Management Systems – Global Pipeline Summary
GlobalData's Medical Devices sector report, "Innovations in Hospital Management Systems - Global Pipeline Summary" provides comprehensive information about the Hospital Management Systems pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Hospital Management Systems report provides key information and data related to: Extensive coverage of the Hospital Management Systems under development Review details of major pipeline products which include product description, licensing and collaboration details and other developmental...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Anakinra in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anakinra in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anakinra in Hospital Acquired Pneumonia (HAP) Drug Details: Anakinra...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nacubactam in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nacubactam in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nacubactam in Hospital Acquired Pneumonia (HAP) Drug Details: Nacubactam...
-
Product Insights
Kemerovo City – Leninsky Infectious Diseases Hospital – Kemerovo
The Kemerovo City – Leninsky Infectious Diseases Hospital – Kemerovo involves the construction of an infectious diseases hospital on a 28,600m2 area for 11,000 patients in the Leninsky District, Kemerovo, Russia. Equip yourself with the essential tools needed to make informed and profitable decisions with our Kemerovo City – Leninsky Infectious Diseases Hospital – Kemerovo report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (Avibactam Sodium + Aztreonam) in Hospital Acquired Pneumonia (HAP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Avibactam Sodium + Aztreonam) in Hospital Acquired Pneumonia (HAP) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Avibactam Sodium + Aztreonam) in Hospital...
-
Product Insights
fastigheter – Varnamo Hospital Psychiatric Building – Joenkoeping
The fastigheter – Varnamo Hospital Psychiatric Building – Joenkoeping involves the construction of a psychiatric building at Varnamo Hospital in Jonkoping County, Sweden. Equip yourself with the essential tools needed to make informed and profitable decisions with our fastigheter – Varnamo Hospital Psychiatric Building – Joenkoeping report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of...
-
Product Insights
Likelihood of Approval Analysis for Hospital Acquired Pneumonia (HAP)
Overview How likely is it that the drugs in Hospital Acquired Pneumonia (HAP) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hospital Acquired Pneumonia (HAP) Overview Hospital-acquired pneumonia (HAP) is defined...
-
Product Insights
Varha – TYKS T-Hospital Extension – Southwest Finland
The Varha – TYKS T-Hospital Extension – Southwest Finland involves the construction of 16,300m2 T-hospital’s additional building with 8,700m2 of functional space in Turku, Southwest Finland, Finland. Equip yourself with the essential tools needed to make informed and profitable decisions with our Varha – TYKS T-Hospital Extension – Southwest Finland report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and...
-
Product Insights
CAMH – Toronto Mental Health Hospital Phase 1D Redevelopment – Ontario
The CAMH – Toronto Mental Health Hospital Phase 1D Redevelopment – Ontario involves the redevelopment of two buildings comprising a 33-bed mental health facility in Toronto, Ontario, Canada. Equip yourself with the essential tools needed to make informed and profitable decisions with our CAMH – Toronto Mental Health Hospital Phase 1D Redevelopment – Ontario report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the...
-
Product Insights
NewHospital Acquired Pneumonia (HAP) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Hospital Acquired Pneumonia (HAP) Clinical Trial Report Overview A total of 581 HAP clinical trials were conducted as of April 2024. The HAP clinical trial report provides a comprehensive understanding of the HAP clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions ·      North America ·      Europe...